2021-01 |
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma |
YONSEI MEDICAL JOURNAL
|
2021-01 |
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir |
JOURNAL OF VIRAL HEPATITIS
|
2020-12 |
A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy |
JOURNAL OF VIRAL HEPATITIS
|
2020-12 |
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion |
Journal of hepatocellular carcinoma
|
2020-12 |
Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2020-11 |
Effect of urea cream on sorafenib-associated hand?foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study |
EUROPEAN JOURNAL OF CANCER
|
2020-11 |
Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
2020-11 |
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization |
GUT AND LIVER
|
2020-11 |
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals |
Cancers
|
2020-11 |
High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis |
JOURNAL OF VIRAL HEPATITIS
|
2020-11 |
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B |
DIGESTIVE AND LIVER DISEASE
|
2020-11 |
Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria |
RADIOTHERAPY AND ONCOLOGY
|
2020-09 |
Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack |
CEREBROVASCULAR DISEASES
|
2020-09 |
Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus |
GUT AND LIVER
|
2020-09 |
Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma |
JOURNAL OF VIRAL HEPATITIS
|
2020-09 |
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation |
Cancers
|
2020-07 |
An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia |
LIVER INTERNATIONAL
|
2020-07 |
Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study |
GUT AND LIVER
|
2020-07 |
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma |
Clinical and molecular hepatology
|
2020-07 |
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
2020-06 |
Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea |
CURRENT MEDICAL RESEARCH AND OPINION
|
2020-06 |
Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2020-05 |
Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: A korean nationwide, multicenter, prospective, observational, cohort study |
NUTRIENTS
|
2020-05 |
Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
2020-05 |
Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib forAdvanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
2020-04 |
A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea |
PLOS ONE
|
2020-04 |
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
2020-03 |
Awareness and Access to Therapy in Hepatitis C Virus Infected Patients, Key Barriers to Eliminate the Virus? |
GUT AND LIVER
|
2020-03 |
Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma |
HEPATOLOGY INTERNATIONAL
|
2020-03 |
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2020-03 |
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase |
Clinical and Translational Gastroenterology
|
2020-03 |
An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate |
JOURNAL OF VIRAL HEPATITIS
|
2020-03 |
Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
2020-02 |
HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines |
JOURNAL OF CANCER
|
2020-02 |
Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma |
STRAHLENTHERAPIE UND ONKOLOGIE
|
2020-01 |
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea |
Clinical and molecular hepatology
|
2020-01 |
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases |
Intestinal research
|
2020-01 |
Hepatocellular carcinoma risk steadily persists over time despite long-term antiviral therapy for hepatitis B: A multicenter study |
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
|
2020-01 |
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection |
Clinical and molecular hepatology
|
2020-01 |
Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging |
HEPATOLOGY INTERNATIONAL
|
2020-01 |
Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study |
MODERN RHEUMATOLOGY
|
2020-01 |
Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
2020-01 |
Genetically engineered mouse models for liver cancer |
Cancers
|
2019-12 |
Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy |
SCIENTIFIC REPORTS
|
2019-12 |
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis |
DIGESTIVE DISEASES AND SCIENCES
|
2019-12 |
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B |
Clinical and molecular hepatology
|
2019-12 |
Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
2019-12 |
Intraindividual Comparison between Gadoxetate- Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study |
KOREAN JOURNAL OF RADIOLOGY
|
2019-10 |
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis |
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
|
2019-10 |
Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits |
ULTRASONOGRAPHY
|
2019-10 |
Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study |
PLOS ONE
|
2019-10 |
Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database |
CANCER RESEARCH AND TREATMENT
|
2019-09 |
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir |
Clinical and molecular hepatology
|
2019-09 |
External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy |
LIVER INTERNATIONAL
|
2019-09 |
Postoperative recurrence of hepatocellular carcinoma: The importance of distinguishing between intrahepatic metastasis and multicentric occurrence-response |
CLINICAL CANCER RESEARCH
|
2019-09 |
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation |
CANCER MEDICINE
|
2019-09 |
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea |
JOURNAL OF HEPATOLOGY
|
2019-08 |
Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma |
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
|
2019-07 |
Radiomics on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma |
CLINICAL CANCER RESEARCH
|
2019-06 |
Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea |
ANNALS OF SURGICAL TREATMENT AND RESEARCH
|
2019-06 |
Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals |
Clinical and Translational Gastroenterology
|
2019-04 |
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization |
Cancers
|
2019-04 |
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma |
BMC CANCER
|
2019-04 |
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection |
PLOS ONE
|
2019-04 |
Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma |
RADIOTHERAPY AND ONCOLOGY
|
2019-03 |
Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status |
GUT AND LIVER
|
2019-03 |
Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model |
GUT AND LIVER
|
2019-03 |
Subclinical but significant liver fibrosis in patients with ANCA-associated vasculitis |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
|
2019-03 |
Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis |
Journal of Clinical Medicine
|
2019-03 |
Evaluation of Early Response to Treatment of Hepatocellular Carcinoma with Yttrium-90 Radioembolization Using Quantitative Computed Tomography Analysis |
KOREAN JOURNAL OF RADIOLOGY
|
2019-03 |
Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma |
DIGESTIVE AND LIVER DISEASE
|
2019-02 |
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals |
SCIENTIFIC REPORTS
|
2019-02 |
Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma |
RADIOTHERAPY AND ONCOLOGY
|
2019-02 |
Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients |
CEREBROVASCULAR DISEASES
|
2019-01 |
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
|
2019-01 |
진행성 간세포암종의 새로운 전신 치료제 |
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
|
2019-01 |
Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers |
LIVER INTERNATIONAL
|
2018-10 |
HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma |
CANCER RESEARCH AND TREATMENT
|
2018-09 |
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
2018-09 |
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial |
BMC CANCER
|
2018-09 |
Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib |
LIVER INTERNATIONAL
|
2018-08 |
Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
2018-08 |
HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study |
RHEUMATOLOGY INTERNATIONAL
|
2018-06 |
Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update? |
HEPATOLOGY
|
2018-05 |
Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety |
GUT AND LIVER
|
2018-04 |
Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B |
LIVER INTERNATIONAL
|
2018-04 |
Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
2018-03 |
Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion" |
AMERICAN JOURNAL OF ROENTGENOLOGY
|
2018-03 |
Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study |
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
|
2018-03 |
Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B |
GUT AND LIVER
|
2018-03 |
Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance |
JOURNAL OF MEDICAL VIROLOGY
|
2017-12 |
Validation of the PAGE-B Model in Asian Chronic Hepatitis B Patients Receiving Entecavir or Tenofovir |
LIVER INTERNATIONAL
|
2017-11 |
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy |
GUT AND LIVER
|